Einar Stefánsson

Dr. Stefánsson is a leading physician in the field of diabetic eye disease and diabetic eye screening. Dr. Stefánsson has co-founded four biotechnology firms in addition to Oculis, including Cyclops ehf. which was acquired by DeCode Genetics in 2000. He contributes to a number of ophthalmological publications either as chief editor or on the editorial board. Dr. Stefánsson was knighted by the President of Iceland in 2007 and received a number of awards in science and ophthalmology, such as Iceland’s highest award in science in 2008 and the gold medal of the European Academy of Ophthalmology in 2014 among many other honours. Dr. Stefánsson has published more than 300 peer-reviewed international publications, more than 400 abstracts, numerous book chapters and patents. Dr. Stefánsson received a degree in medicine from the University of Iceland Medical School and a Ph.D. in physiology from Duke University followed by a residency and faculty position at Duke. He has served as Vice Dean and Dean of the Faculty of Medicine at the University of Iceland and served as Professor and Chair of the Department of Ophthalmology at the National University Hospital in Iceland since 1993.